Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
Laura Hillebrand, Xiaojun Julia Liang, Ricardo Augusto Massarico Serafim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7668-7758
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Demystifying Functional Parameters for Irreversible Enzyme Inhibitors
David E. Heppner, Blessing C. Ogboo, Daniel A. Urul, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 17, pp. 14693-14696
Closed Access | Times Cited: 11
Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on SNAr Electrophiles
Moritz Schwarz, Maksym Kurkunov, Florian Wittlinger, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6549-6569
Closed Access | Times Cited: 8
Lazertinib: Breaking the mold of third-generation EGFR inhibitors
Kishan B. Patel, David E. Heppner
RSC Medicinal Chemistry (2025)
Open Access | Times Cited: 1
Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach
Eric M. Merten, John D. Sears, Tina M. Leisner, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 42
Closed Access | Times Cited: 7
New insights into protein–protein interaction modulators in drug discovery and therapeutic advance
Hossam Nada, Yongseok Choi, Sung-Do Kim, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Identification of Dihydropyrazolo[1,5-a]pyrazin-4(5H)-ones as Cyclic Products of β-Amidomethyl Vinyl Sulfone Alphavirus Cysteine Protease Inhibitors
Anirban Ghoshal, Álvaro F. Magalhães, Kesatebrhan Haile Asressu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 836-836
Open Access | Times Cited: 5
Development of an Irreversible Peptidomimetic Radioligand for PET Imaging of ST14 Protease
Tukang Peng, Gang Huang, Haitao Zhao, et al.
Bioconjugate Chemistry (2025)
Closed Access
Targeted Covalent Modification Strategies for Drugging the Undruggable Targets
Tomonori Tamura, Masaharu Kawano, Itaru Hamachi
Chemical Reviews (2025)
Closed Access
32nd Annual GP2A Medicinal Chemistry Conference
Jean‐Jacques Hélesbeux, Florence O. McCarthy, Maria Manuel Silva, et al.
Drugs and Drug Candidates (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access
JAK3 Inhibitors: Covalent and Noncovalent Interactions of a Cyanamide Group Investigated by Multiscale Free-Energy Simulations
Laura Scalvini, Daniele Pala, Alberto Cuzzolin, et al.
Journal of Chemical Information and Modeling (2025)
Closed Access
Unleashing the Power of Covalent Drugs for Protein Degradation
Meng‐Jie Fu, Hang Jin, Shao‐Peng Wang, et al.
Medicinal Research Reviews (2025)
Closed Access
Total syntheses of cyclohelminthol I–IV reveal a new cysteine-selective covalent reactive group
Thomas T. Paulsen, Anders E. Kiib, Gustav J. Wørmer, et al.
Chemical Science (2025)
Open Access
A Medicinal Chemistry Perspective on FDA-Approved Small Molecule Drugs with a Covalent Mechanism of Action
Samuel E. Dalton, Ornella Di Pietro, Elisabeth T. Hennessy
Journal of Medicinal Chemistry (2025)
Closed Access
Discovery of The Clinical Candidate S-892216: A Second-Generation of SARS-CoV-2 3CL Protease Inhibitor for Treating COVID-19
Yuto Unoh, Keiichiro Hirai, Shota Uehara, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
A covalent chemical probe for Chikungunya nsP2 cysteine protease with antialphaviral activity and proteome-wide selectivity
Anirban Ghoshal, Edwin G. Tse, Mohammad Anwar Hossain, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Medicinal Chemistry: A Key Driver in Achieving the Global Sustainable Development Goals
Bianca Martinengo, Eleonora Diamanti, Elisa Uliassi, et al.
Journal of Medicinal Chemistry (2025)
Open Access
Identification of an Allene Warhead That Selectively Targets a Histidine Residue in the Escherichia coli Oxidoreductase Enzyme DsbA
Yildiz Tasdan, Gautham R. Balaji, Naureen Akhtar, et al.
ACS Medicinal Chemistry Letters (2025)
Closed Access
O-Cyanobenzaldehydes Irreversibly Modify Both Buried and Exposed Lysine Residues in Live Cells
Huan Ling, Lin Li, Liping Duan, et al.
Journal of the American Chemical Society (2025)
Closed Access
Covalent inhibitors possessing autophagy-modulating capabilities: charting novel avenues in drug design and discovery
Yutong Wang, Shiyu Luo, Hongbao Sun, et al.
Drug Discovery Today (2025), pp. 104347-104347
Closed Access
Factors affecting irreversible inhibition of EGFR and influence of chirality on covalent binding
Pasquale A. Morese, Ayaz Ahmad, Mathew P. Martin, et al.
Communications Chemistry (2025) Vol. 8, Iss. 1
Open Access
Structure Activity of β-Amidomethyl Vinyl Sulfones as Covalent Inhibitors of Chikungunya nsP2 Cysteine Protease with Antialphavirus Activity
Anirban Ghoshal, Kesatebrhan Haile Asressu, Mohammad Anwar Hossain, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 18, pp. 16505-16532
Open Access | Times Cited: 4
Evaluation of a Covalent Library of Diverse Warheads (CovLib) Binding to JNK3, USP7, or p53
Theresa Klett, Martin Schwer, Larissa N. Ernst, et al.
Drug Design Development and Therapy (2024) Vol. Volume 18, pp. 2653-2679
Open Access | Times Cited: 3
Covalent binding of withanolides to cysteines of protein targets
Christian Bailly
Biochemical Pharmacology (2024) Vol. 226, pp. 116405-116405
Open Access | Times Cited: 3
Structure Activity of β-Amidomethyl Vinyl Sulfones as Covalent Inhibitors ofChikungunyansP2 Cysteine Protease with Anti-alphavirus Activity
Anirban Ghoshal, Kesatebrhan Haile Asressu, Mohammad Anwar Hossain, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Ligand discovery by activity-based protein profiling
Micah J. Niphakis, Benjamin F. Cravatt
Cell chemical biology (2024) Vol. 31, Iss. 9, pp. 1636-1651
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top